ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $597,000 | -42.3% | 328,196 | 0.0% | 0.22% | -33.6% |
| Q2 2022 | $1,034,000 | -49.0% | 328,196 | 0.0% | 0.33% | -20.5% |
| Q1 2022 | $2,028,000 | -56.5% | 328,196 | 0.0% | 0.42% | -37.0% |
| Q4 2021 | $4,660,000 | +77.5% | 328,196 | 0.0% | 0.66% | +123.4% |
| Q3 2021 | $2,626,000 | -72.0% | 328,196 | 0.0% | 0.30% | -72.2% |
| Q2 2021 | $9,377,000 | -4.2% | 328,196 | -2.6% | 1.06% | +14.6% |
| Q1 2021 | $9,786,000 | +16.2% | 336,869 | -52.3% | 0.93% | -26.6% |
| Q4 2020 | $8,419,000 | +38.1% | 705,693 | -22.7% | 1.26% | -23.5% |
| Q3 2020 | $6,096,000 | -34.3% | 912,693 | -39.1% | 1.65% | -35.0% |
| Q2 2020 | $9,284,000 | +37.4% | 1,497,448 | -11.4% | 2.54% | -9.3% |
| Q1 2020 | $6,759,000 | -28.1% | 1,689,848 | -1.2% | 2.80% | -6.5% |
| Q4 2019 | $9,404,000 | +63.2% | 1,709,848 | 0.0% | 2.99% | +68.3% |
| Q3 2019 | $5,762,000 | +116.8% | 1,709,848 | +57.6% | 1.78% | +162.2% |
| Q2 2019 | $2,658,000 | -64.1% | 1,084,848 | -50.0% | 0.68% | -56.6% |
| Q1 2019 | $7,396,000 | +224.7% | 2,169,696 | +100.0% | 1.56% | -7.5% |
| Q4 2018 | $2,278,000 | -30.0% | 1,084,848 | 0.0% | 1.69% | +9.7% |
| Q3 2018 | $3,256,000 | – | 1,084,848 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |